|
| |
Day
1 :
February 1, 2007 (Pre-symposium Workshop) |
| 10.00
hrs |
Spot
Registration |
| 10.30 hrs
onwards |
Workshop |
| 17.00 –
19.00 hrs |
Social
Hours for all delegates |
| 19.00
hrs |
Dinner |
|
| Day
2 :
February 2, 2007 |
| 09.00
to 09.40 hrs |
Inauguration
ceremony |
|
Session
I
GLUCOSE METABOLISM AND ENERGY BALANCE |
Chairpersons
- Dr.
S. D. Sheth, Consultant, ICMR
- Dr.
Richard DiMarchi, Indiana University
|
| 09.45
to 10.30 hrs |
Keynote
address (PL-1)
|
“An
RNAi-based approach to understanding metabolic disease”
Dr.
Michael Czech, Ph.D.
Professor, Department of Biochemistry and
Molecular Biology, and Director of the
Program in Molecular Medicine
University of Massachusetts, USA |
| 10.30 to
11.00 hrs |
Tea
break |
| 11.00 to
11.35 hrs |
Invited
Lecture
(IL-01)
|
"Glucose
as a signal to control energy homeostasis"
Dr.
Bernard Thorens
Professor of Physiology
Center for Integrative Genomics
University of Lausanne, Switzerland |
| 11.35
to 12.10 hrs |
Invited
Lecture
(IL-02)
|
“Insulin
and AMPK signalling in Skeletal Muscle: Validation of targets
to prevent and treat Type 2 Diabetes Mellitus”
Dr.
Juleen R. Zierath
Professor of Physiology
Department of Molecular Medicine and
Surgery
Karolinska Institute, Sweden |
| 12.10
to 12.45 hrs |
Invited
Lecture
(IL-03)
|
“Forkhead
transcription factors & Diabetes”
Dr.
Markus Stoffel
Robert and Harriet Heilbrunn Professor,
Rockefeller University, USA |
| 12.45 to
13.15 hrs |
Invited
Lecture
(IL-04)
|
“Cannabinoids
and their regulation of metabolic syndrome”
Dr.
Prasenjit Mitra
Group Leader
Zydus Research Centre |
| 13.15
to 15.00 hrs |
|
Lunch,
Poster & Networking |
Session
II
ISLETS AND ENDOTHELIAL DYSFUNCTION |
Chairpersons
- Dr.
Robert Henry, Professor of Medicine, University of California
San Diego
|
| 15.00
to 15.35 hrs |
Invited
Lecture
(IL-05)
|
"Signal
integration in the endocrine pancreas"
Dr.
Per-Olof Berggren
Professor and Head, Experimental
Endocrinology at the Karolinksa Institute,
Stockholm, Sweden
Head of Cell Biology and Signal Tranduction
and the Mary Lou Held Visiting Scientist at
the Diabetes Research Institute, and Adjunct
Professor of Surgery at University of Miami,
USA |
| 15.35
to 16.10 hrs |
|
"An
Industry Perspective on New Therapeutic Approaches to Metabolic
Disease"
Dr. David E. Moller, MD
Vice President, Endocrine and Cardiovascular
Research and Clinical
Investigation
Lilly Research Laboratories, USA |
| 16.10
to 16.30 hrs |
|
Tea
break |
| 16.30
to 17.05 hrs |
Invited
Lecture
(IL-07)
|
“AGPAT
Isoforms and the Cellular Response to Fatty Acids”
Dr.
Charles Burant, M.D., Ph.D.
Associate Professor
Metabolism, Endocrinology & Diabetes
University of Michigan, USA |
| 17.05
to 17.35 hrs |
Invited
Lecture
(IL-08)
|
“Spatial
and temporal regulation of insulin granule exocytosis”
Dr.
Susumu Seino, M.D.
Professor
Division of Cellular & Molecular Medicine
Kobe University School of Medicine, Japan |
| 17.35
to 18.30 hrs |
Panel
discussion |
Chairperson
Dr.
Richard DiMarchi, USA |
| Day
3 :
February 3, 2007 |
Session
III
HORMONES, NUCLEAR RECEPTORS AND METABOLISM
(ADIPOKINE, INCRETIN, INSULIN RESISTANCE, SIGNALING PATHWAYS, PPAR’s) |
Chairpersons
- Dr.
C. M. Gupta, Director, CDRI, India
- Dr.
Per-Olof Berggren, Karolinska Institute, Sweden
|
| 09.15
to 10.00 hrs |
Invited
Lecture
(IL-09)
|
"Integrated
Neurohormonal Therapy for Obesity"
Dr.
Alain Baron
Senior Vice President, Research
Amylin
|
| 10.00
to 10.35 hrs |
Invited
Lecture
(IL-10)
 |
“Cross-talk
between nuclear receptors in metabolic
control and cardiovascular disease"
Dr.
Bart Staels
INSERM
Institut Pasteur de Lille, France |
| 10.35
to 11.00 hrs |
|
Tea
break |
| 11.00
to 11.35 hrs |
Invited
Lecture
(IL-11)
|
“Multifaceted
role of PPAR gamma in the adipose tissue”
Dr.
Walter Wahli
Director, Center for Integrative Genomics
Switzerland |
| 11.35
to 12.10 hrs |
Invited
Lecture
(IL-12)
 |
"Antiatherogenic
properties of PPARgamma activators - novel effects beyond
glucose control"
Dr.
Nikolaus Marx
Professor
University of Ulm, Germany |
| 12.10
to 12.45 hrs |
Invited
Lecture
(IL-13)
|
“Therapeutic
mechanisms of PPAR gamma modulators”
Dr.
Silvia Corvera
Professor
Program in Molecular Medicine
University of Massachusetts, USA |
| 12.45
to 13.20 hrs |
Invited
Lecture
(IL-14)
|
"PPAR
Based Therapy -How Do We Design Safer Compounds?"
Dr.
Ashish Goel
Principal Scientist
NCE Discovery
Department of Cell Biology and Biochemistry
Zydus Research Centre |
| 13.20
to 15.00 hrs |
|
Lunch,
Posters & Networking |
| Session
IV
ADVANCES IN TYPE 2 DIABETIC THERAPY |
Chairpersons
- Dr.
P. Rama Rao, NIPER, India
- Dr.
Michael Czech, University of Massachusetts, USA
|
| 15.00
to 15.45 hrs |
Keynote
address (PL-4)
|
“Depot-Specific
Regulation of Human Adipose Tissue Adiponectin Secretion”
Dr.
Robert R. Henry, M.D., FRCP (C) (Ed)
Professor of Medicine
University of California San Diego
Chief, Section of Diabetes, Endocrinology &
Metabolism
Director, Center for Metabolic Research
VA San Diego Healthcare System, USA
|
| 15.45
to 16.20 hrs |
|
“New
avenues in the Treatment of Type 2 Diabetes: Targeting insulin
resistance beyond HbA1c - PPARs and non PPARs”
Dr.
Elena Sebokova, Ph.D., D.Sc.
F. Hossmann La-Roche Ltd,
Disease Area Head Metabolic Disease,
Basel, Switzerland |
| 16.20
to 16.35 hrs |
|
Tea
Break |
| 16.35
to 17.10 hrs |
|
“Thiazolidinediones
in Type 2 Diabetes: Indian Experience”
Dr.
Anil Bhansali
Professor & Head, Endocrinology Postgraduate Institute
of Medical Education & Reasearch, India
|
| 17.10
to 17.45 hrs |
Invited
Lecture
(IL-17) |
Dr.
Satinath Mukherjee
Associat Professor, Department of Endocrinology & Metabolism,
Institute of Post Graduate Medical Education & Research,
Kolkata, India |
| 17.45
to 18.30 hrs |
|
Chairperson
Dr.
Michael Czech, Ph.D., USA
|
| 18.30 |
|
Cultural
Evening |
| Day
4 :
February 4, 2007 |
Session
V
DIABETES, DYSLIPIDEMIA AND RELATED COMPLICATIONS
(NEPHROPATHY, NEUROPATHY, AND RETINOPATHY) |
Chairpersons
- Dr.
Shukant M. Sadikot, President, Diabetes, India
- Dr.
Alain Baron, Senior Vice President, Research, Amylin
|
| 09.00
to 09.45 hrs |
Keynote
address (PL-5)
|
"The
emergence of chemical biotechnology and its
application to endocrine proteins"
Dr.
Richard DiMarchi
Retired Group Vice President, Eli Lilly Research labs.
Professor of Chemistry and the Jack and Linda Gill
Distinguished Chair in Biomolecular Science, Indiana
University, USA |
| 09.45 to
10.20 hrs |
Invited
Lecture
(IL-17)
|
“Pulmonary
Methods of Delivery for Peptides and Proteins --Inhaled Insulin”
Dr.
Viren Sarin
Senior Research Fellow, Eli Lilly & CO., Indianapolis,
USA
|
| 10.20
to 10.40 hrs |
Tea
Break |
| 10.40
to 11.15 hrs |
Invited
Lecture
(IL-18)
|
"BI
1356, a novel potent and selective xanthine based DPP-IV inhibitor,
exhibits a unique profile"
Dr Michael Mark
Vice President, Metabolic Diseases Research, Boehringer-Ingelheim,
|
| 11.15
to 11.50 hrs |
Invited
Lecture
(IL-19)
|
“Trends
and Opportunities in Diabetes and the Metabolic Syndrome”
John
H. Johnson, Ph.D.
Director, Licensing and Development, Pfizer Inc.
|
| 11.50
to 12.15 hrs |
Best
Poster Presentations (Best Poster 1&2 - 10 min. each) |
| 12.15
to 13.30 hrs |
Panel
discussion |
|
| 13.30
hrs |
|
Vote
of thanks & closing ceremony |
| 13.45
hrs |
|
Lunch |
|
